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Abstract: Variants in more than 271 different genes have been linked to hereditary retinal diseases,
making comprehensive genomic approaches mandatory for accurate diagnosis. We explored the
genetic landscape of retinal disorders in consanguineous families from North-Western Pakistan,
harboring a population of approximately 35 million inhabitants that remains relatively isolated and
highly inbred (~50% consanguinity). We leveraged on the high degree of consanguinity by applying
genome-wide high-density single-nucleotide polymorphism (SNP) genotyping followed by targeted
Sanger sequencing of candidate gene(s) lying inside autozygous intervals. In addition, we performed
whole-exome sequencing (WES) on at least one proband per family. We identified 7 known and 4 novel
variants in a total of 10 genes (ABCA4, BBS2, CNGA1, CNGA3, CNGB3, MKKS, NMNAT1, PDE6B,
RPE65, and TULP1) previously known to cause inherited retinal diseases. In spite of all families
being consanguineous, compound heterozygosity was detected in one family. All homozygous
pathogenic variants resided in autozygous intervals ≥2.0 Mb in size. Putative founder variants
were observed in the ABCA4 (NM_000350.2:c.214G>A; p.Gly72Arg; ten families) and NMNAT1
genes (NM_022787.3:c.25G>A; p.Val9Met; two families). We conclude that geographic isolation
and sociocultural tradition of intrafamilial mating in North-Western Pakistan favor both the clinical
manifestation of rare “generic” variants and the prevalence of founder mutations.
Keywords: hereditary retinal diseases; autozygosity mapping; consanguinity; Pakistan
1. Introduction
Inherited retinal dystrophies (IRDs) constitute a genetically heterogeneous group of rare conditions
of the eye. They are mainly characterized by the progressive loss of rod and/or cone photoreceptors,
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resulting in complete or nearly complete blindness at the end [1]. Globally, IRDs affect approximately
one million people, with a frequency of 1 in 3000 births. Clinically, they may range from mild and
non-progressive night blindness to more severe and degenerative phenotypes, including retinitis
pigmentosa (RP) and cone or cone-rod dystrophies [2]. To date, mutations in over 271 genes have
been linked to various forms of IRDs (RetNet; https://sph.uth.edu/RETNET/; accessed on 12 December
2019), and the sequencing of their coding parts has allowed the detection of pathogenic mutations in
more than 60% of the patients [3]. IRDs are inherited as an autosomal recessive, autosomal dominant,
X-linked, or mitochondrial trait, with autosomal recessive being the most prominent type [1,4]. Recent
technological advancements, such as next-generation sequencing (NGS), have significantly increased
gene discovery rates in a wide range of inherited ocular conditions [5], with a sensitivity value of
~75%, when applied to a clinically focused IRDs group [6]. Since consanguinity unmasks the adverse
effects of recessive mutations through bi-parental inheritance of the same allele, it is possible to
reveal the presence of disease-causing variants in consanguineous pedigrees by simply flagging large
segments of consecutive homozygous genotypes surrounding the mutations, using a technique called
“autozygosity mapping” [7–10]. For a more rapid and robust analysis, scientists usually combine
autozygosity mapping with NGS to maximize the acquisition of relevant genetic information [10].
The combination of such information with targeted functional studies has provided significant insights
into the molecular mechanisms of rare Mendelian diseases, including IRDs.
Since children of consanguineous couples are more likely than children of non-consanguineous
parents to be affected by recessive genetic anomalies [11], the incidence of rare Mendelian diseases
is higher in populations having a high degree of endogamy [12]. For example, Pakistan has one of
the highest rates of inherited genetic diseases in the world, likely due to the fact that consanguinity is
present in more than 50% of the population and marriages among first cousins are highly favored by
the society [13,14]. According to a recent estimate, approximately 1.12 million people in Pakistan are
blind, and the vision loss burden has continued to rise in the country since 1990 [15].
Although some information exists on blindness caused by cataracts or refractive errors,
the prevalence of IRDs is not well documented in Pakistan at the level of the whole population.
A hospital-based study in Karachi, a metropolitan city, revealed that 1 in 800 patients who visited the
ophthalmic outpatient department had retinal dystrophies, with RP being the most frequent type (64%),
followed by Stargardt disease (14.7%) and cone dystrophies (6.7%). Unsurprisingly, more than half of the
patients from this study were born to consanguineous parents [16]. Recently, a few studies on IRDs have
been published in Pakistan [17–20]. However, the majority of these reports were based on pedigrees
from the Punjab and Sindh provinces, thus leaving North-Western Pakistan largely unexplored.
Administratively known as Khyber Pakhtunkhwa (KP), this part of the country is predominantly a
Pashtuns territory and includes a heterogeneous population of approximately 35 million inhabitants.
Consanguinity in KP ranges between 22% and 66%, and the rate of consanguinity was found to have
increased over time, possibly due to the growing violence and geo-political conflicts in the region
(consanguineous marriages are believed to strengthen pre-existing intra-familial relationships and thus
be advantageous in the context of civil unrest) [21–25]. To our knowledge, no comprehensive study on
the genetic spectrum of IRDs has ever been undertaken in North-Western Pakistan, possibly because
of socio-economic and cultural limitations, a lack of infrastructure, difficult terrain, and escalating
conflicts in the region.
2. Materials and Methods
2.1. Enrollment of Families and Collection of Samples
Our study conforms to the standards of the Declaration of Helsinki and was approved by
the Institutional Review Boards of the Hazara University, Mansehra, Pakistan (approval code:
F.No:185/HU/Zool/2018/583) and of all our respective Institutions. Informed consents were provided
in written form by all families prior to their participation and were signed by all members who
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were enrolled. Families with at least two or more affected persons, a history of consanguinity, and
a clear autosomal recessive inheritance pattern of the disease were selected for molecular analysis.
All families participating in our study were ethnically Pashtuns and were geographically located in
the KP province in North-Western Pakistan. Clinical and demographic information was obtained
via a pre-designed questionnaire, and pedigrees were drawn and cross-checked through face-to-face
interviews with patients and/or elder members of the family, in their native language. Clinical data were
obtained either directly from the patients’ medical reports (if available) or through consultation with
the local clinicians/ophthalmologists who examined them on our request. Due to the limited medical
infrastructure in the region, detailed clinical investigations, such as electroretinography (ERG) or
fundus images, were not available. Furthermore, most of the clinical information obtained was derived
from self-reported data, including, for example, difficulties in day/night vision, photophobia, disease
onset and progression, response to medication, outcome of the Ishihara test, dark/light adaptation,
ability to see/focus near and distant objects, loss of central or peripheral vision, and nystagmus. Patients
were also investigated for other parameters, such as their ability to perform routine activities, e.g.,
reading, doing physical activities, and socializing with people. Electronic versions of pedigrees were
created using the Pedigree Chart Designer (CeGaT, Tubingen, Germany). Saliva samples were collected
by using the Oragene saliva kit (OG-500, DNA Genotek, Ottawa, ON, Canada) from patients as well
as their clinically unaffected relatives, following the manufacturer’s guidelines. DNA was extracted
from these samples following standard protocols, e.g., by following the prepIT-L2P manual (DNA
Genotek, Canada). Quantitative and qualitative assessments of DNA were made using the NanoDrop™
1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA, USA) and electrophoresis on 1%
agarose gels.
2.2. Genotyping and Homozygosity Mapping
Initially, nine families were subjected to genetic analysis using genome-wide high-density
single-nucleotide polymorphism (SNP) arrays. For this purpose, genomic DNA of two or more
individuals per family was genotyped by using the InfiniumCoreExome-24v1-1 array (Illumina,
San Diego, CA, USA), which encompasses ~550,000 genome-wide SNP markers, at the iGE3 Genomics
Platform of the University of Geneva, Switzerland. Arrays were processed using an iScan, according
to the manufacturer’s protocol. Genotype calls were generated using the GenomeStudio software by
Illumina. PLINK was used to analyze the genotype data [26]. Following the identification of shared
autozygous intervals among two or more patients from the same family, all exons and exon–intron
boundaries of candidate gene(s) inside these intervals were sequenced using the Sanger method.
Additionally, families that belonged to the same geographic area and had clinically overlapping
phenotypes were also investigated for the presence of shared autozygous intervals. Using this method,
putative disease-causing variants were identified in four consanguineous pedigrees segregating
autosomal recessive IRDs, while the remaining unsolved families were subsequently characterized by
whole-exome sequencing (WES).
2.3. Whole-Exome Sequencing
Overall, WES was performed for 10 pedigrees. For WES analysis, 2.0 µg of genomic DNA
from index patients was initially processed by Novogene Co. Ltd (Hong Kong, China). Sequencing
libraries were generated using the Agilent SureSelect Human All ExonV6 kit (Agilent Technologies,
Santa Clara, CA, USA), while fragmentation was carried out by hydrodynamic shearing (Covaris,
Massachusetts, MA, USA). Following adapter ligation, DNA fragments were selectively enriched in
a PCR reaction. Products were purified using the AMPure XP system (Beckman Coulter, Beverly,
CA, USA) and quantified using an Agilent high-sensitivity DNA assay on the Agilent Bioanalyzer
2100 system. Captured DNA libraries underwent paired-end sequencing on an Illumina Novaseq
6000 S4 platform, resulting in sequences of 150 bases (PE150 sequencing strategy). WES data were
analyzed using our in-house computational pipeline [27], and autozygosity mapping was done
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using AutoMap (unpublished). Finally, Sanger sequencing was performed to validate the potentially




As mentioned earlier, detailed clinical investigation could not be achieved for all patients. However,
a summary of the clinical information of one family is shown in Figure S1. On the basis of the few
data available, mostly based on patients’ symptoms, we could identify five major clinical IRD classes.
Briefly, patients with severe early-onset blindness were tentatively categorized as individuals with
Leber congenital amaurosis (LCA, two families), while patients presenting with IRD and extra-ocular
symptoms such obesity, hypogonadism, learning/developmental disabilities, post-axial polydactyly of
hands and/or feet, and renal abnormalities were examined by a local clinician who classified them as
suffering from Bardet–Biedl syndrome (BBS) (two families). Patients with progressive loss of central
vision were categorized as having macular dystrophy (eleven families), while those presenting with
initial night blindness and progressive loss of peripheral vision were classified as suffering from RP
(four families). Patients with RP were clinically evaluated with the help of a local ophthalmologist who
reported the presence of bilateral bone spicules and peripheral retinal vascular attenuation, through
fundus examination. Lastly, patients with a complete inability to discriminate between colors were
classified as having achromatopsia (one family).
3.2. Molecular Findings
Collectively, we identified 11 disease-causing variants in 10 IRD-associated genes, in a total of
20 consanguineous IRDs pedigrees, all from North-Western Pakistan (Table 1). These variants were
detected using a genome-wide SNP array followed by Sanger sequencing (four families), WES (ten
families), and targeted Sanger sequencing alone (six families). Of these variants, seven were previously
known IRD mutations, while four variants had never been identified before. Newly detected changes
comprised three protein-truncating mutations and one nonsynonymous single-nucleotide variant
(SNV). While the pathogenicity of protein-truncating variants can be easily postulated, the causality of
the nonsynonymous SNV was inferred through in silico analysis and segregation studies. In spite
of all families being consanguineous, compound heterozygosity was detected in one family (PK-E).
All homozygous pathogenic variants were detected inside tractable autozygous intervals (≥2.0 Mb in
size) and co-segregated with the disease in homozygosis in members from the remaining 19 families,
including those who were not pre-ascertained by means of homozygosity mapping (Figure 1). Putative
founder mutations were observed in the ABCA4 (NM_000350.2:c.214G>A; p.Gly72Arg; 10 families)
and in the NMNAT1 genes (NM_022787.3:c.25G>A; p.Val9Met; 2 families), which together accounted
for more than half of the IRD pedigrees analyzed in this study.
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PK004 ACHM CNGA3 NM_001298.2 c.847C>T p.Arg283Trp 0.0001402 M1 Hom 5-Mb WES [28]
PK-H BBS MKKS NM_170784.2 c.280T>C p.Phe94Leu NA M2 Hom 10-Mb SNP array This study
PK006 BBS BBS2 NM_031885.3 c.1438C>T p.Arg480Ter 0.00001647 M3 Hom 31-Mb SNP array [29]
PK-L LCA NMNAT1 NM_022787.3 c.25G>A p.Val9Met NA M4 Hom 2-Mb SNP array [30]
PK-M LCA NMNAT1 NM_022787.3 c.25G>A p.Val9Met NA M4 Hom 2-Mb SNP array [30]
PK001 RP TULP1 NM_001289395.1 c.1307A>G p.Lys436Arg 0.00002472 M5 Hom 17-Mb WES [31]
PK007 RP CNGA1 NM_001142564.1 c.1298G>A p.Gly433Asp NA M6 Hom 21-Mb WES [18]
PK009 MD CNGB3 NM_019098.4 c.1574_1575del p.Phe525Ter NA M7 Hom 39-Mb WES This study
PK010 RP RPE65 NM_000329.2 c.550G>T p.Glu184Ter NA M8 Hom 21-Mb WES This study
PK002 RP PDE6B NM_001145291.1 c.427del p.Ala143LeufsTer7 NA M9 Hom 4-Mb WES This study
PK-E MD ABCA4 NM_000350.2 c.3081T>G p.Tyr1027Ter NA M10 Het NA SNP-WES [32]
PK-E MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Het NA SNP-WES [33]
PK-B MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom 7-Mb SNP-WES [33]
PK-P MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom NA TSS [33]
PK-F MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom 24-Mb SNP-WES [33]
PK-D MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom 24-Mb SNP-WES [33]
PK028 MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom NA TSS [33]
PK034 MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom NA TSS [33]
PK037 MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom NA TSS [33]
PK038 MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom NA TSS [33]
PK043 MD ABCA4 NM_000350.2 c.214G>A p.Gly72Arg 0.00002784 M11 Hom NA TSS [33]
MAF: Minor allele frequency; NA: Not available; Hom: Homozygous; Het: Heterozygous; ROH: Runs of homozygosity; WES: Whole-exome sequencing; TSS: Targeted Sanger sequencing.
ACHM: Achromatopsia; BBS: Bardet–Biedl syndrome; LCA: Leber congenital amaurosis; RP: Retinitis pigmentosa; MD: Macular dystrophy.
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3.3. Macular Dystrophy (Possibly Including Stargardt Disease and Cone-Rod Degeneration)
Following SNP-based autozygosity mapping in three apparently unrelated families (PK-B, PK-D,
and PK-F), we initially identified a ~2.0 Mb autozygous interval on chromosome 1, which was shared
by three probands belonging to these families (Figure 1). Interestingly, the ABCA4 gene was residing
inside this interval, and an approximately 100 kb haplotype flanking this gene was identical in all three
patients. WES analysis revealed a homozygous missense variant (NM_000350.2:c.214G>A:p.Gly72Arg)
in ABCA4. The same variant (p.Gly72Arg) was also present in a compound heterozygous state with a
nonsense mutation (NM_000350.2:c.3081T>G:p.Tyr1027Ter) in an additional family (PK-E) belonging
to the same geographic location. Both of these variants have previously been identified to cause
Stargardt disease [32,33]. Next, we performed targeted Sanger sequencing for p.Gly72Arg in a cohort of
18 previously uncharacterized consanguineous pedigrees from the region and identified the p.Gly72Arg
mutation in six of them, in homozygosis. In total, p.Gly72Arg was found to cause disease in at least
10 independent pedigrees from a small town in North-Western Pakistan, collectively accounting for
37 patients (Figure 2). Geographically, these families belonged to Darra Adam Khel in North-Western
Pakistan, an area which is mainly inhabited by the Afridi clan of Pashtuns ethnicity. Since these
families were from the same geographic region and had a common ethnic affiliation, and an identical
haplotype around ABCA4 was detected in the three patients who were investigated for it, we believe
that p.Gly72Arg constitutes a founder mutation.
Furthermore, WES analysis in family PK009 revealed a nonsense variant (NM_019098.4:c.1574
_1575del:p.Phe525Ter) in the CNGB3 gene, which co-segregated with the disease in homozygosis
(Figure 2). This variant has never been reported in any public databases and constitutes a loss-of-function
allele, therefore likely representing the molecular cause of disease in this family.
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Figure 2. Segregation analysis of the mutations detected in a total of 20 consanguineous pedigrees 
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Figure 2. Segregation analysis of the mutations detected in a total of 20 consanguineous pedigrees from
North-Western Pakistan. Probands in each pedigree are indicated by arrows. Due to space limitations,
all pedigrees were trimmed.
3.4. Retinitis Pigmentosa
Through whole-exome sequencing in four consanguineous families with autosomal recessive
RP, we identified disease-causing variants in four IRD-associated genes. These included:
TULP1 (NM_001289395.1:c.1307A>G:p.Lys436Arg; family PK001), PDE6B (NM_001145291.1:
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c.427del:p.Ala143LeufsTer7; family PK002), CNGA1 (NM_001142564.1: c.1298G>A:p.Gly433Asp; family
PK007), and RPE65 (NM_000329.2:c.550G>T:p.Glu184Ter; family PK010). All genes harboring these
variants were located inside autozygous intervals with a genomic size of ≥2 Mb (Figure 1). All variants
were validated by Sanger sequencing and confirmed to co-segregate with the disease in all affected family
members (Figure 2). While variants identified in the TULP1 (NM_001289395.1:c.1307A>G:p.Lys436Arg)
and in the CNGA1 (NM_001142564.1: c.1298G>A:p.Gly433Asp) genes were formerly known to cause
RP [18,31], DNA changes in PDE6B and in RPE65 have never been reported in any public databases.
Since they are both loss-of-function variants (nonsense and frame-shift variants), they can be assumed
to represent bona fide mutations.
3.5. Leber Congenital Amaurosis (Early-Onset Retinal Blindness)
Using SNP-based autozygosity mapping in two families with early-onset visual problems (PK-L,
PK-M), we identified an autozygous interval on chromosome 1 that was shared by both probands
from these families (Figure 1). Since NMNAT1, residing in this region, was a suitable candidate gene
for LCA, we screened all exons and exon–intron boundaries of this gene, using Sanger sequencing.
We found a missense variant (NM_022787.3:c.25G>A:p.Val9Met) in exon 2 that co-segregated with the
disease in both families (Figure 2). The same variant (p.Val9Met) was previously reported to cause
LCA in a pedigree of Pakistani descent [30]. However, we could not establish whether this previously
identified family had any relationship with the pedigrees analyzed in our study. Considering the
geographic proximity of these families, we suggest that p.Val9Met in NMNAT1 constitutes another
example of a founder mutation in North-Western Pakistan.
3.6. Bardet–Biedl Syndrome
Again, autozygosity mapping identified common intervals on chromosomes 16 and 20 in two
families (PK006 and PK-H) with BBS (Figure 1); these intervals included the BBS2 and the MKKS genes,
respectively. In affected members of family PK006, the previously reported homozygous nonsense
mutation BBS2:NM_031885.3:c.1438C>T:p.Arg480Ter was found [29], whereas family PK-H segregated
a novel missense mutation (MKKS:NM_170784.2:c.280T>C:p.Phe94Leu). Both BBS2 and MKKS variants
co-segregated with the disease in a homozygous state and were present heterozygously in healthy
individuals from both families (Figure 2). The MKKS variant was found to result in the disruption
of a highly conserved amino acid (Phe94) and was predicted to be highly deleterious by numerous
online prediction tools such as PolyPhen-2, PROVEAN, Mutation Taster, SIFT, MutationTaster2,
and LRT [34–39]. Additionally, the variant was never identified in any public databases, including The
Genome Aggregation Database (gnomAD), The Exome Aggregation Consortium (ExAC), and The
Human Gene Mutation Database (HGMD) [40–42].
3.7. Achromatopsia
Through exome sequencing in a consanguineous pedigree (PK004) with three affected children
suffering from putative complete achromatopsia, we identified a homozygous nonsynonymous
single-nucleotide variant (NM_001298.2:c.847C>T:p.Arg283Trp) in the CNGA3 gene. Autozygosity
mapping revealed the CNGA3 gene to lie within a 5 Mb autozygous interval on chromosome 2 (Figure 1).
The mutation is a known cause of achromatopsia [28].
4. Discussion
Pakistan has one of the highest prevalence of inherited genetic diseases in the world [13], likely
due to the high consanguinity rate of its population, generally exceeding 50% [11,12,14]. In this country,
marriages of first cousins are highly favored, and families from Pakistan are considered a valuable
resource for medical genetics research, which has led to significant scientific findings in the recent
past [13,43]. Several studies on IRDs have been conducted in Pakistan during the last few years, but the
majority of them were based on pedigrees from the Punjab and Sindh provinces [17–20]. Khan et
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al. [20] showed that 90% of the mutations for non-syndromic IRDs and 100% of the mutations for
syndromic IRDs were specific to families of Pakistani origin and that mutations in 35 different genes
were found to cause non-syndromic IRDs specifically in families of Pakistani descent. In our study,
we observed a different trend: out of the 11 mutations identified, only 4 were novel, whereas the
remainder had previously been reported in patients from China, the UK, and Germany, and only two
of them were found in Pakistani residents [28,29,31–33]. This probably reflects the fact that we focused
our analysis on pedigrees from the North-Western part of the country, which remains largely isolated
from populations inhabiting central Pakistan for cultural, linguistic, and geographic reasons. Further,
North-Western Pakistan is predominantly a Pashtuns territory and, in contrast to central Pakistan,
these populations trace their lineage to Pashtuns living in Western Afghanistan, with whom they share,
even today, linguistic and sociocultural affiliations.
Our data therefore provide a first insight into the genetic landscape of IRDs in this peculiar part
of the world, slightly extending the known mutational spectrum of IRDs. In particular, we have
reported two founder mutations (ABCA4:c.214G>A:p.Gly72Arg and NMNAT1:c.25G>A:p.Val9Met)
that, together, were responsible for disease in more than half of the patients in our study. At least 37
patients from 10 different families were found to be affected by the mutation in ABCA4, while the
NMNAT1 mutation touched at least 6 people in two unrelated families. Owing to the high rates of
traditional intra-familial marriages, strong socio-cultural and ethnic divides, as well as geographic
barriers, we predict that the number of patients/families affected by these two founder mutations
may be even higher. Furthermore, a considerable number of variants identified in our study were
detected inside large autozygous intervals (≥10 Mb), thus reflecting recent endogamy in the population.
Similarly, our data support the previous notion that the likelihood for a homozygous pathogenic variant
to be found within one autozygous interval is much higher in consanguineous pedigrees [10,44–46].
In summary, our study explored the genetic landscape of inherited retinal diseases in
North-Western Pakistan, a large but relatively ignored part of the country. In addition to detecting a
high degree of autozygosity and relevant founder mutations in the region, our data further expand
the mutational spectrum of IRD-associated genes by adding four new variants to it. These findings
will help future researchers/clinicians in their rapid screenings of patients from this region and will
assist families seeking genetic counselling. We also predict that these insights on eye disorders might
apply to other rare conditions that affect individuals from this region, such as deafness, intellectual
disabilities, and developmental defects.
Supplementary Materials: The following are available online at http://www.mdpi.com/2073-4425/11/1/12/s1,
Figure S1: Clinical features from the proband of family PK-H (MKKS:NM_170784.2:c.280T>C:p.Phe94Leu). Fundus
images of the patient’s right (A) and left (B) eye. Post-axial polydactyly of the right (C) and left (D) foot, indicated
by red arrows.
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